Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of a single-dose orally inhaled DNAzyme solution for nebulisation in adult male asthma patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DNAzyme Solution for Nebulisation (DNAzyme)

Snippet

Sponsor: Sterna Biologicals GmbH & Co. KG | Conditions: Asthma | Phase 1 | Status: COMPLETED